Drugs modulating stochastic gene expression affect the erythroid differentiation process by Guillemin, Anissa et al.
HAL Id: hal-02375801
https://hal.archives-ouvertes.fr/hal-02375801
Submitted on 22 Nov 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Drugs modulating stochastic gene expression affect the
erythroid differentiation process
Anissa Guillemin, Ronan Duchesne, Fabien Crauste, Sandrine Gonin-Giraud,
Olivier Gandrillon
To cite this version:
Anissa Guillemin, Ronan Duchesne, Fabien Crauste, Sandrine Gonin-Giraud, Olivier Gandrillon.
Drugs modulating stochastic gene expression affect the erythroid differentiation process. PLoS ONE,
Public Library of Science, 2019, 14 (11), pp.1-19. ￿10.1371/journal.pone.0225166￿. ￿hal-02375801￿
RESEARCH ARTICLE
Drugs modulating stochastic gene expression
affect the erythroid differentiation process
Anissa GuilleminID1, Ronan Duchesne1,2, Fabien Crauste2,3, Sandrine Gonin-Giraud1,
Olivier Gandrillon1,2*
1 Laboratoire de biologie et mode´lisation de la cellule. LBMC - Ecole Normale Supe´rieure - Lyon, Universite´
Claude Bernard Lyon 1, Centre National de la Recherche Scientifique: UMR5239, Institut National de la Sante´
et de la Recherche Me´dicale: U1210 - Ecole Normale Supe´rieure de Lyon 46 alle´e d’Italie 69007 Lyon,
France, 2 Inria Dracula, Villeurbanne, France, 3 Univ. Bordeaux, CNRS, Bordeaux INP, IMB, UMR 5251,
F-33400, Talence, France
* olivier.gandrillon@ens-lyon.fr
Abstract
To better understand the mechanisms behind cells decision-making to differentiate, we
assessed the influence of stochastic gene expression (SGE) modulation on the erythroid dif-
ferentiation process. It has been suggested that stochastic gene expression has a role in
cell fate decision-making which is revealed by single-cell analyses but studies dedicated to
demonstrate the consistency of this link are still lacking. Recent observations showed that
SGE significantly increased during differentiation and a few showed that an increase of the
level of SGE is accompanied by an increase in the differentiation process. However, a con-
sistent relation in both increasing and decreasing directions has never been shown in the
same cellular system. Such demonstration would require to be able to experimentally
manipulate simultaneously the level of SGE and cell differentiation in order to observe if cell
behavior matches with the current theory. We identified three drugs that modulate SGE in
primary erythroid progenitor cells. Both Artemisinin and Indomethacin decreased SGE and
reduced the amount of differentiated cells. On the contrary, a third component called MB-3
simultaneously increased the level of SGE and the amount of differentiated cells. We then
used a dynamical modelling approach which confirmed that differentiation rates were indeed
affected by the drug treatment. Using single-cell analysis and modeling tools, we provide
experimental evidence that, in a physiologically relevant cellular system, SGE is linked to
differentiation.
Introduction
Cell-to-cell variability is intrinsic to all living forms, from prokaryotes [1, 2] to eukaryotes [3].
Such variability originates from many sources, but arguably stochastic gene expression (SGE)
is an important driving force in the generation of cell-to-cell variability among genetically
identical cells [4], although additional regulation layers do exist [5]. Classically, SGE is sepa-
rated into intrinsic and extrinsic sources [6–10] even if in many cases distinguishing between
the two is difficult.
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The very existence of SGE led to the concept of a probabilistic mapping between inputs
(environment) and outputs (cell decisions) [11]. It is therefore clear that SGE has to be pre-
cisely tuned so as to tailor the biological process in which it is involved [12, 13].
As an inevitable consequence of the molecular nature of gene expression process, it is clear
that mechanisms dedicated to its control must exist. For example, it has been discussed that
during the development, to ensure the reliable reproduction of some particular patterns, cell-
signaling devices (e.g. the Wnt pathway) act as a noise-filter [14].
By contrast, numerous arguments suggest that SGE variation plays an important role in a
wide range of biological processes ranging from bet hedging [15] to the fractional killing of
cancer cells [16]. The involvement of SGE in decision-making has been shown in viruses [17–
19], in prokaryotes [20–22] and, more recently, in metazoan cells [22–24]. Evidences of its role
in the differentiation ability began to emerge from literature through different points of view.
First, the theoretical arguments [25–27], based on evidence of cell-to-cell heterogeneity but
without any experimental demonstration, represent differentiation seen from a dynamical
point of view [28]: undifferentiated cells exhibit a stable gene expression pattern corresponding
to a pre-existing self-renewal state. Once differentiation is activated through external factors,
cells could increase their SGE, explore a broader region of their state space and exhibit a mixed
gene expression identity between the original and the destination states. Such an exploratory
behaviour would increase the probability for cells to attain the space region where they stabi-
lize their new gene expression pattern by reaching another pre-existing stable state: the differ-
entiation state [26, 27]. In other words, an increase of SGE would lead to an improvement of
the differentiation dynamic [26]. In addition, it has been described that, in a transition state,
the original state may be removed as the gene expression values change, making the process
irreversible [27, 29, 30]. Collectively, it has been largely discussed that stochastic fluctuations,
associated with extrinsic inputs, appear to be the main means by which cells can change their
state [22, 27, 30]. However, this theoretical point of view needs to be supported by biological
observations.
Secondly, observation of the role of SGE during differentiation emerged, some years later,
through experimental measures of the amount of SGE during differentiation processes [31–
34]. We recently described a surge in cell-to-cell variability that precedes an irreversible differ-
entiation of normal primary chicken erythroid progenitors called T2EC [35], that is fully com-
patible with such a view [31]. Interestingly, these results have been confirmed in various
settings, ranging from the differentiation of murine lymphohematopoietic progenitors [33] to
the differentiation of murine embryonic stem cells [32, 34].
Finally, experimental demonstrations such as studies of artificial modulation of the amount
of SGE [13, 36] started to emerge. These last types of evidences aim at reinforcing the consis-
tency of the relation between SGE and differentiation but a clear demonstration and character-
ization of this link is still lacking. Here, we pave the way toward this demonstration, adding a
new complementary study to the legacy.
To do so, it is necessary to show that pharmacological modulators such as drugs [12, 13, 36]
would on one hand modify SGE and, on the other hand modulate the differentiation process.
It has recently been described that such drugs, identified using a large screening approach,
were able to modulate the noise affecting a LTR-driven reporter gene in human T-lymphocytes
[37]. In addition, drugs that directly inhibit promoter nucleosome remodelling were also
shown to provide fine-tuning of SGE [38].
In order to demonstrate the general aspect of the relation between SGE and differentiation,
we decided to explore the extent to which some of those drugs, that are able to reduce
(Artemisinin and Indomethacin) or to increase (MB-3, [7]) the level of SGE, could alter
differentiation.
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Here we show that the three selected drugs modify, significantly and simultaneously, the
level of SGE and the rate of cell differentiation. We therefore provide a clear evidence that, in a
physiologically relevant cellular system, a pharmacological modulation of SGE is positively
and consistently accompanied by a modification of differentiation, as suggested by existing
points of view.
Materials and methods
Cell culture and treatment
T2EC were extracted from the bone marrow of 19 days-old SPAFAS white leghorn chickens
embryos (INRA, Tours, France). These cells were maintained in a medium called LM1. It is
composed of α-MEM medium supplemented with 10% Foetal bovine serum (FBS), 1 mM
HEPES, 100 nM β-mercaptoethanol, 100 U/mL penicillin and streptomycin, 5 ng/mL TGF-α,
1 ng/mL TGF-β and 1 mM dexamethasone as previously described [35]. T2EC were induced
to differentiate by removing the LM1 medium and placing cells into the DM17 medium (α-
MEM, 10% foetal bovine serum (FBS), 1 mM Hepes, 100 nM β-mercaptoethanol, 100 U/mL
penicillin and streptomycin, 10 ng/mL insulin and 5% anemic chicken serum (ACS)). Differ-
entiation kinetics were obtained by collecting cells at different times after the induction in dif-
ferentiation. For Indomethacin and Artemisinin, cells in the self-renewing medium are treated
at respectively 25 μM and 1 μM 48h before switching into a differentiated medium in order to
optimize their effects. For MB-3 ((2R,3S)-rel-4-Methylene-5-oxo-2-propyltetrahydrofuran-
3-carboxylic acid), cells are treated at 10 μM just after inducing the differentiation. For each
drug, a control treatment (0.1% DMSO) was added following the same conditions.
Counting of cell viability and cell differentiation
Cell population growth was evaluated by counting living cells using a Malassez cell and Trypan
blue staining (SIGMA). This method was also used to assess the toxicity of the drugs in T2EC
(S6 Fig). Cell population differentiation was evaluated by counting differentiated cells using a
counting cell and Benzidin (SIGMA) staining which stains haemoglobin in blue.
Dynamical model for erythroid differentiation
Every detail regarding the design, selection, calibration or identifiability analysis of our
dynamic model can be found in its original paper [39]. All data and pieces of code used for the
curent study are available in a public github repository https://github.com/rduchesn/Drugs-
modulating-stochastic-gene-expression-affect-the-erythroid-differentiation-process. Herein,
we give only the definitions of the useful concepts and methods in this study.
Model definition. Dynamic model The ODE governing the time-evolution of the cell
populations in each compartment of the model are given in Eq 1:
dS
dt
¼ rSSðtÞ   dSCSðtÞ; ð1aÞ
dC
dt
¼ rCCðtÞ þ dSCSðtÞ   dCBCðtÞ; ð1bÞ
dB
dt
¼ rBBðtÞ þ dCBCðtÞ: ð1cÞ
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It is characterized by the set (ρS, δSC, ρC, δCB, ρB) of five parameters, where ρi is the net pro-
liferation rate of compartment i (positive or negative), and δij is the differentiation rate of cell
type i into cell type j, which is positive.
The solution to this linear ODE model is given in the supplementary materials of the origi-
nal paper [39]. We will note fi(tj, y0, θ) the prediction of this model for the ith observable of the
experiment, on the jth timepoint tj, with the initial condition y0 and parameters θ.
Error model In order to properly define the statistical likelihood of our model, we intro-
duce a gaussian model for the distribution of the residuals of the dynamic model:
yi;j;k ,!N ðfiðtj; y0; yÞ; bi:fiðtj; y0; yÞÞ; ð2Þ
where yi,j,k is the experimental measure for the ith observable, at the jth timepoint, in the kth
repetition of the experiment. Here bi is an error parameter which quantifies the variance of the
model residuals, and should be estimated together with the parameters θ of the dynamic
model.
Estimation in the control case. Likelihood From Eq 2, the likelihood of the model natu-
rally follows, and we can estimate the best-fit parameter values of the model by minimizing the
negative logarithm of the likelihood:
  2 logðLÞ ¼
Xn
i¼1
Xm
j¼1
Xl
k¼1
ðyi;j;k   fiðtj; yÞÞ
bi:fiðtj; y0; yÞ
 !2
þ 2 logðbi:fiðtj; y0; yÞÞ; ð3Þ
where n is the number of observables of the model, m the number of timepoints, and l the
number of repetitions of the measurements.
Algorithmic details We minimized −2 log(L) using the Truncated Newton’s algorithm [40,
41] implemented in the python package for scientific computing scipy [42]. Convergence to
the global minimum was assured by a random sampling of the initial guesses for parameter
values.
Estimation under treatment. Parameter variations The model has seven parameters
(five dynamic parameters: ρS, δSC, ρC, δCB and ρB; and two error parameters: b1 and b2), of
which six are estimated from the data. Under a given treatment, we consider that each esti-
mated parameter could either be estimated from the data, or set equal to its control value. For
each treatment, this defines 26 = 64 different models, with a varying number of additional
parameters to estimate.
Model selection We estimated the parameter values of these 64 models for each treatment,
and selected the best models by computing their corrected Akaike’s Information Criterion
[43]:
AICc ¼   2 logðLÞ þ
2kn
n   k   1
: ð4Þ
where k is the number of parameters of the model and n is the sample size. From the corrected
AIC, we compute the Akaike’s weights:
wi ¼
expð  ðAICci   minðAICcÞÞ=2Þ
PR
j¼1 expð  ðAICci   minðAICcÞÞ=2Þ
; ð5Þ
where wi is the Akaike’s weight of the i-th model, and R = 64 is the number of competing mod-
els. The Akaike’s weight of a given model in a given set of models can be seen as the probability
that it is the best one among the set [43]. In this setting, selecting the best models of a set of
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models means computing their Akaike’s weights, sorting them, and keeping only the models
whose weights add up to a significance probability (in our case, 95%).
Single cell high-throughput RTqPCR
Every experiment related to high-throughput microfluidic-based RT-qPCR was performed
according to Fluidigm’s protocol (PN 68000088 K1, p.157-172) and recommendations. All
the following steps from single-cell isolation to high throughput RTqPCR of each cells are
described in [31].
Entropy
We estimated the Shannon entropy of each gene j at each timepoint t as follows: we computed
basic histograms of the genes with N = Nc /2 bins, where Nc is fixed for all tests, which pro-
vided the probabilities ptj;k of each class k. Finally, the entropies were defined by
Etj ¼  
XN
k¼1
ptj;k log 2ðp
t
j;kÞ:
When all cells express the same amount of a given gene, this gene’s entropy will be null. On
the contrary, the maximum value of entropy will result from the most variable cell-to-cell gene
expression level.
Results
Drugs affect noise
In order to characterize the relation between SGE and differentiation, we first make sure to be
able to change the amount of SGE in T2EC using three drug treatments: Artemisinin, Indo-
methacin and MB-3.
Artemisinin and Indomethacin are known to modify SGE of the HIV LTR promoter in
human T-lymphocytes [37]. MB-3, a chromatin modifier, is known to modify stochastic gene
expression in yeast [7] and in murine embryonic stem cells [13]. At first, we wanted to confirm
that these drugs do indeed modify SGE in our cellular system and to determine the mecha-
nisms associated with this effect.
We treated T2EC with or without drugs and induced their erythroid differentiation. We
then performed single-cell high-throughput RTqPCR on these cells at different time points
after differentiation. We assessed a 92 gene panel, relevant for erythroid differentiation study,
identical to those previously measured in untreated cells [31].
There are various ways of quantifying the amount of so-called “noise” in gene expression.
Unfortunately, no consensus has emerged with authors advocating for the use of normalized
variance (NV = σ2/μ2) and claiming that the use of Fano Factor (F = σ2/μ) might be misleading
[44, 45], whereas others defend the exact opposite position [46]. The use of the coefficient of
variation (CV = σ/μ) is also known to be limited [45, 47–49].
Both we [31] and others [32, 50, 51] have recently proposed the shannon entropy as an
alternative measure, that is dedicated to quantify cell-to-cell variability. For our purpose and
based on its mathematical definition, a deterministic pattern of expression exhibits low
entropy whereas a high entropy indicates a more diverse expression pattern [31, 50]. We there-
fore analyzed our single-cell transcriptomic data using this metric.
We can observe in (Fig 1A) that the entropy was affected by all treatments. Under Indo-
methacin or Artemisinin treatment, entropy significantly decreased after 2 days of erythroid
differentiation. This effect was more pronounced with Indomethacin. The opposite effect is
Role of stochastic gene expression during differentiation process
PLOS ONE | https://doi.org/10.1371/journal.pone.0225166 November 21, 2019 5 / 19
observed with the MB-3-based treatment, for which entropy was significantly increased after
12h of differentiation (Fig 1A).
We then assessed whether the same genes exhibit entropy variations under the different
drug treatments or not. To do so, we computed a correlation value between the entropy varia-
tions for each pair of drugs. If the same genes are affected by two drugs, then one would expect
their entropy variations to be correlated. We observed a significant correlation only for the
genes affected by Indomethacin and Artemisinin treatment. MB-3 treatment seemed to affect
the variability of a different set of genes (Fig 1B).
Fig 1. Relative effect of entropy and average gene expression level under drug treatment during differentiation.
(A) Boxplots representing values of entropy per gene for each treatment relative to control values (red dotted line).
Some outliers are not displayed for readability. We assessed the significance of the differences between untreated and
treated conditions through a Wilcoxon test (tests with a p-value< 0.05 are represented by a star above each boxplot).
(B) Correlation plots representing relative values of entropy per gene for each pair of drugs. We assessed the
significance of the differences between values for each drug through a Pearson test (p-value< 0.05). When the
correlation is significant, we displayed the linear regression line for all points (red dotted lines). (C) Correlation plots
representing relative values of entropy as a function of relative values of cell mean expression per gene. We assessed the
significance of the differences between values for each drug through a Pearson test (p-value< 0.05). When the
correlation is significant, we displayed the linear regression line for all points (red dotted lines).
https://doi.org/10.1371/journal.pone.0225166.g001
Role of stochastic gene expression during differentiation process
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The entropy variation could be achieved by modulating the global mean gene expression or
the gene expression variance. Thus we finally wanted to test if our drug treatments affected
entropy through the modulation of the mean gene expression value. If so, one might expect to
see a correlation between the variation of entropy and the mean expression level under drug
treatment.
Indeed for two drugs out of three, Artemisinin and MB-3, we observed a significant inverse
correlation between mean and entropy (Fig 1C). Nevertheless the effect of Indomethacin on
entropy was not related to an effect on mean gene expression.
Here we have found three drugs that modulate SGE in T2EC cells. Indomethacin and Arte-
misinin decreased it whereas MB-3 increased it. MB-3 involved a different set of genes than
Artemisinin and Indomethacin (also shown in S1 Fig) and the effect of drugs was not strongly
related to an effect on mean gene expression value. Entropy modulation is therefore the only
common characteristic of our three drugs.
Even with a weak correlation, it seems that Artemisinin and Indomethacin could affect the
same genes to change the level of SGE. Thus, we decided to get more insight on genes targeted
by each drugs by selecting genes of interest in function of the influence of drugs on them
(Table 1).
We observed that for some of the genes that we studied, the entropy was affected by both
Indomethacin and Artemisinin. We therefore decided to focus our analysis more specifically
on these genes.
From the Shannon entropy value of each gene for each condition, we calculated the relative
value for each treatment compared to the control and reordered these results from the highest
ratio to the weakest. For a given gene in a given treatment, if this relative entropy value is very
different from one, it means that the entropy of that gene was greatly affected by the treatment.
In such a way, genes are represented in function of their entropy ratio values from top to bot-
tom as the most positively affected by drugs to the most negatively affected (Table 1). The gene
expression distributions of the most affected genes (negatively and positively) for each drugs
were represented in S2 Fig. The first quartile of the resulting distribution of relative entropy
indicates genes for the entropy was the most positively affected by the treatment. Conversely,
the third quartile indicates genes for which the entropy was the most negatively affected by the
treatment.
We can observe that for Indomethacin and Artemisinin treatments, the 3 top genes that
are the most positively affected by the drugs in variability are the same: ALAS1, TPP1 and
MFSD2B. Whereas, for MB-3, the relative entropy of TPP1 and ALAS1 genes are negatively
affected (under the third quartile). Such as Indomethacin and Artemisnin, MB-3 affected posi-
tively the entropy of MFSD2B. We can also find the gene MKNK2 as a common positively
affected gene for Indomathacin and Artemisinin (all their relative entropy values are superior
to the first quartile). Under MB-3 treatment, the relative entropy of MKNK2 does not seem to
be affected as its value is between the first and the third quartile (Table 1). For the genes that
are most negatively affected by drugs, the results are less clear. Under the third quartile, we can
find MTFR1 and LDHA for both Artenisinin and Indomethacin. For MB-3, LDHA is nega-
tively affected. HRAS1 is also negatively affected by Artemisinin and Indomethacin but its
value is not under the third quartile for the Indomethacin treatment. HRAS1 is positively
affected under the MB-3 treatment but for MTFR1, the relative entropy value is unchanged
(Table 1). Regarding gene expression distributions, the most positively affected genes (in
terms of entropy), show wider distribution in the treated condition than in the control (S2
Fig). The inverse is true with the most negatively affected genes. That supports the relevance of
the indicator used, Shannon’s entropy. Moreover, all the distributions are heavy-tailed, which
is expected from mRNA single cell distributions [52].
Role of stochastic gene expression during differentiation process
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Table 1. Relative entropy values. Here are displayed the gene entropy values across cells for each treatment normalized by the control condition. Bold values represent
entropy ratio strictly superior to the first quartile (q1, top values) or strictly inferior to the third quartile (q3, bottom values). Genes represented are the genes which
RTqPCR quality control passed. The time points used to show these values are the same as in Fig 1A. Values are ordered from the highest to the lowest ratio. Genes in bold
are those on which we have focused. RE = Relative Entropy.
INDOMETHACIN ARTEMISININ MB-3
Genes RE Genes RE Genes RE Genes RE
ALAS1 1.8455 MFSD2B 1.6275 ACSL6 4.7113 WDR91 1.1068
TPP1 1.4769 TPP1 1.5182 AMDHD2 3.1564 HSD17B7 1.1061
MFSD2B 1.4329 ALAS1 1.4970 GPT2 2.8459 GSN 1.1055
AMDHD2 1.3961 MKNK2 1.4845 PLAG1 2.4347 DPP7 1.0989
GPT2 1.3151 CYP51A1 1.4429 SQLE 2.4193 SULT1E1 1.0959
MKNK2 1.3005 PLS1 1.3522 CYP51A1 2.2100 TADA2L 1.0708
EGFR 1.2545 CRIP2 1.3489 EMB 1.8670 PIK3CG 1.0682
FNIP1 1.0539 VDAC3 1.1979 RPL22L1 1.8081 SLC25A37 1.0479
FHL3 0.9916 FDFT1 1.1695 BCL11A 1.7895 BETA-GLOBIN 1.0463
DHCR24 0.9906 LCP1 1.1626 FDFT1 1.7042 STX12 1.0313
EMB 0.9718 HSP90AA1 1.1299 SLC9A3R2 1.6493 NSDHL 1.0148
SMPD1 0.9609 PIK3CG 1.0756 BATF 1.6040 MKNK2 0.9976
HMGCS1 0.9580 q1 TBC1D7 1.5405 RSFR 0.9514
q1 STARD4 1.0726 SMPD1 1.5150 LCP1 0.9367
PIK3CG 0.9183 SLC6A9 1.0507 VRK3 1.4939 q3
SLC6A9 0.8871 EGFR 1.0281 UCK1 1.4604 PPP1R15B 0.8977
SLC9A3R2 0.8849 HMGCS1 1.0235 RFFL 1.4594 STARD4 0.8758
GLRX5 0.8844 FHL3 0.9984 HSP90AA1 1.4416 DHCR24 0.8593
RBM38 0.8261 DCTD 0.9938 HRAS1 1.4317 RUNX2 0.8558
CYP51A1 0.7558 SULT1E1 0.9741 TTYH2 1.4216 ALAS1 0.8556
FDFT1 0.7508 SQSTM1 0.9674 MAPK12 1.4154 BPI 0.8393
BETA-GLOBIN 0.7245 UCK1 0.9656 q1 TPP1 0.8330
STX12 0.7230 GAB1 0.9256 FNIP1 1.4070 LDHA 0.8306
CRIP2 0.7086 EMB 0.9168 GLRX5 1.3965 SCA2 0.8176
CREG1 0.6893 GLRX5 0.9032 HYAL1 1.3823 CD44 0.8141
PDLIM7 0.6750 NCOA4 0.9010 DHCR7 1.3723 SULF2 0.7960
REXO2 0.6438 DHCR24 0.8958 MFSD2B 1.3401 SCD 0.7788
SQLE 0.6427 FNIP1 0.8904 CTSA 1.3288 CRIP2 0.7530
GAB1 0.6423 PDLIM7 0.8738 VDAC3 1.3207 HMGCS1 0.7420
CTCF 0.6247 CTCF 0.8496 PTPRC 1.2901 DCTD 0.7298
HRAS1 0.5975 SULF2 0.8332 CD151 1.2687 SERPINI1 0.7197
HSP90AA1 0.5646 GPT2 0.8289 RBM38 1.2577 PDLIM7 0.6980
VDAC3 0.5511 SMPD1 0.8124 REXO2 1.2559 ACSS1 0.6950
UCK1 0.5481 BETA-GLOBIN 0.7950 PLS3 1.2558 SNX22 0.6351
RPL22L1 0.5424 VRK3 0.7881 EGFR 1.2491 SNX27 0.5169
NCOA4 0.5184 DCP1A 0.7837 MVD 1.2472 FAM208B 0.2530
SULT1E1 0.5174 TBC1D7 0.7654 SQSTM1 1.2446
q3 q3 PLS1 1.2412
TBC1D7 0.5109 CREG1 0.7399 AACS 1.2411
PLS1 0.5022 STX12 0.7391 CREG1 1.2202
LCP1 0.4868 RPL22L1 0.7372 XPNPEP1 1.2014
SCA2 0.4622 MTFR1 0.6919 SLC6A9 1.1889
LDHA 0.4602 HRAS1 0.6778 ARHGEF2 1.1863
SULF2 0.4267 SLC9A3R2 0.5585 FHL3 1.1835
(Continued)
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As we have shown previously, to modulate the level of SGE, drugs did not target a specific
set of genes. This is clearer for MB-3 compared with the two others than between Indometha-
cin and Artemisinin. However, the increase of the noise level of ALAS1, TPP1 and MFSD2B
seems to be a common effect of Artemisinin and Indomethacin.
In addition, to support these results, we decided to analyse in silico the connections between
the three drugs’ targets.
To do so, we compared the different targets known in literature. For MB-3, the only target
known is KAT2A protein [7, 13, 53]. Indomethacin targets both Cyclooxygenases (COX-1 and
COX-2 also called PTGS for Prostaglandin-Endoperoxide Synthase) [54]. For Artemisinin, the
task to find its targets is more complex because of the unspecificity of this drug [55]. In 2019,
Heller and Roepe listed targets of Artemisinin-based drugs among three proteomic studies
[56].
All together, known connections between proteins were represented using the STRING
database (http://string.embl.de/) in (S1 Fig). Each edge between two proteins corresponds to a
known association between those proteins. We can observe that KAT2A is alone in the con-
nection network. Both PTGS-1 and PTGS-2 are highly correlated together but poorly corre-
lated with the rest of the network. Each link refers to a co-mention between these two terms in
a PubMed Abstract. None of them [57, 58] shows a direct interaction between these molecules.
All these results suggest that there is no direct interaction between the drug targets reported in
the literature. However, we have to keep in mind that we only compare the data reported in lit-
erature and that a potential interaction between drugs remains possible but not yet discovered.
We next used these drugs to test their effect on the erythroid differentiation process.
Drugs affect differentiation
In order to know if drugs modulating SGE also affect the differentiation process, we measured
the percentage of differentiated cells in treated and untreated conditions during 96h of ery-
throid maturation (Fig 2).
A significant modulation in the percentage of differentiated cells was observed for all three
drugs (Fig 2).
Indomethacin and Artemisinin decreased the percentage of mature cells from 48h of differ-
entiation onward. MB-3 acted earlier: it significantly increased the percentage of differentiated
cells by 24h before returning to somewhat below the control level.
Indomethacin and Artemisinin, two drugs that decreased SGE, reduced the percentage of
differentiated cells. Inversely, MB-3 that increased SGE, enhanced the percentage of differenti-
ated cells.
However, at this stage, we cannot conclude that a modification of the level of SGE by drugs
is associated with a change of the differentiation process itself. Indeed, these effects might have
Table 1. (Continued)
INDOMETHACIN ARTEMISININ MB-3
Genes RE Genes RE Genes RE Genes RE
VRK3 0.4040 AMDHD2 0.5245 MTFR1 1.1724
MTFR1 0.3391 SQLE 0.4894 DCP1A 1.1485
STARD4 0.3304 LDHA 0.4151 NCOA4 1.1460
DCTD 0.2950 SCA2 0.3003 CTCF 1.1279
DCP1A 0.2602 REXO2 0.2303 MID2 1.1165
SQSTM1 0.2276 RBM38 0.1613 TNFRSF21 1.1085
https://doi.org/10.1371/journal.pone.0225166.t001
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several origins including modification in growth or death rates of our cells, which we cannot
measure experimentally. To decipher between these effects, we decided to use a mathematical
model describing the dynamics of the in vitro erythroid differentiation [39].
Cellular basis of drug effect
Our model describes the dynamics of three cell populations related to three different stages of
differentiation [39]. The first one is the self renewing state (S) where differentiation has not
started; the third one is the differentiated state (B) where cells have finished differentiating.
The second one is the committed state (C), comprising intermediary cells that are committed
to differentiation but not yet fully differentiated (Fig 3). The dynamics of these compartments
follow a set of linear ODE. From the size of the cell population in the culture (S3 Fig), it seems
reasonable to use a deterministic framework when modelling the growth and differentiation of
the whole population.
Fig 2. Drugs affect erythroid differentiation. Control conditions were averaged (black line) for readability. Shown is
the percentage of differentiated cells for all conditions. Error bars represent the standard-deviation between
experiments (n = 3). We assessed the significance of the differences between each treated condition with their own
control condition through a student test (p-value< 0.05).
https://doi.org/10.1371/journal.pone.0225166.g002
Fig 3. Schematic diagram of the model.
https://doi.org/10.1371/journal.pone.0225166.g003
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Our dynamic model is characterized by a set of five parameters θ = (ρS, δSC, ρC, δCB, ρB):
• ρi is the proliferation rate of compartment i, involving the balance between cell proliferation
and cell death. This value can be either positive (more proliferation than death) or negative
(more death than proliferation).
• δij is the differentiation rate of cell type i into cell type j, which is positive.
Considering that there remains no self-renewing cells after 2 days of T2EC differentiation (S4
Fig, [31]), δSC is a fixed parameter fully determined by ρS [39].
In order to get the best description of the drugs effects with the fewest parameters, we used
the same approach as described in [39] and in the Methods section.
First, we estimate the parameters of the dynamic model in the control condition, using the
data presented in Fig 2 (living cells and differentiated cells counts in the self-renewal and the
differentiation media). We have already proven that our model identifiable, both theoretically
and practically [39], using the profile likelihood approach [59]. It thus makes sense to compare
the parameter values between the treated and untreated conditions.
For a given treatment, we consider that each parameter could either be equal to its
untreated value, or to another value which should be estimated from the data (thus introduc-
ing a new parameter in the model). We test all the combinations of parameters that might vary
under each treatment, and we select the best ones using Akaike’s weights, that are displayed on
S5 Fig [43].
In the end, the parameter sets that we display in Fig 4 are those that reproduced well, and
with the fewest additional parameters, the cellular kinetics during the in vitro differentiation
(S3 Fig).
For all of those best models, the parameter values for each treatment are displayed in Fig 4.
Under Indomethacin or MB-3 treatment, ρS (net growth rate of the immature cells) was not
affected in all models and slightly decreased under Artemisinin treatment. Therefore, δSC was
not affected by the treatments either, since its value is entirely determined by the value of ρS.
Concerning ρC, the net growth rate of the committed compartment, its values were reduced
compared to the untreated condition for the majority of models under Indomethacin or Arte-
misinin treatment, whereas for MB-3 its value increased in all models.
A more variable change between drug effect was observed with parameter ρB, which
describes the net growth rate of differentiated cells. Under Indomethacin treatment, some of
the best models did not show a different value when compared to untreated condition whereas
Fig 4. Relative parameter values. For each of the models selected by Akaike’s weights (S5 Fig), all the relative
parameter values are represented by a dot for a treatment compared to the untreated condition (black dotted line).
Among all the combinations of parameters that might vary under each treatment, 19 models were selected for the
Indomethacin treatment using Akaike’s weights, 5 for the Artemisinin treatment and 3 for MB-3. The horizontal
spacing between the values of each parameter was chosen randomly for readability.
https://doi.org/10.1371/journal.pone.0225166.g004
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some models displayed a reduced parameter value. Under Artemisinin treatment this value
was unchanged for four models among five and increased for the other one. With MB-3 treat-
ment, ρB decreased in all models.
Finally, we found that the δCB parameter, representing the differentiation rate between
committed compartment and mature cell compartment was affected by all three drugs: both
Indomethacin and Artemisinin reduced this differentiation rate whereas MB-3 increased it in
all best models.
These results demonstrate that all three drugs alter the differentiation process by modifying
all dynamical parameters including the differentiation rate between committed and mature
cells. It is clear that drugs that reduce SGE decrease the differentiation rate T2EC and inversely
that the drugs increasing SGE accelerate cell differentiation, in line with our initial hypothesis.
Discussion
In this study, we highlighted for the first time the existence of a relation between the pharma-
cological modulation of stochastic gene expression and differentiation in both directions
(increase or decrease) in the same cellular system. We first showed that three drugs, selected
from literature [7, 37], increase or decrease the level of SGE in our cells. We therefore tested
their effect on the differentiation ability of avian erythropoietic progenitors. We identified
which differentiation parameters were affected by drugs using a dynamical model of the in
vitro erythroid differentiation [39]. We demonstrated that the modulation of the differentia-
tion process impacted the differentiation rate between the last two compartments. We there-
fore demonstrated that drugs modulating the amount of SGE simultaneously modify the
differentiation process supporting all existing points of view [22, 25–27, 30] and reaching
toward recent experimental evidences [13, 36].
Indomethacin, Artemisinin and MB-3 have clearly different functions. Artemisinin is an
antimalarial drug used against a parasitic infection [53]. Indomethacin is an anti-inflammatory
drug that affects the prostaglandin pathway [54]. These drugs were selected from another
study [37] for their effect on the level of SGE on a HIV LTR promotor in human lymphocyte
line. In this study, Artemisinin and Indomethacin increased the SGE amout of the LTR pro-
motor. The opposite effect between T2EC and the LTR promotor system could have different
origins:
• First, the LTR promotor is the only DNA region analyzed in the original study [37]. In our
study, we analyzed the SGE variation of 92 genes previously selected to be relevant for avian
erythropoiesis.
• Secondly, we analyzed the effect of Artemisinin and Indomethacin on SGE in T2EC as a
sum of each effect on numerous genes. For some of them, the level of SGE was increased
while for the others, the level of SGE was decreased.
• Finally, the cells used in the original study and ours are completely different. The original
study used a line of human T-lymphocytes whereas we used a primary culture of avian ery-
throid progenitors.
MB-3 is an inhibitor of GCN5, a histone acetyl transferase (HAT) that activates global gene
expression [60]. Even in such a seemingly well-defined case, it should nevertheless be remem-
bered that a very complex relationship may lie between the biochemical action of a drug (HAT
inhibition) and its biological effect on SGE [19].
Considering these different functions, it is hard to imagine that all these drugs have in com-
mon anything else than their ability to modulate SGE in T2EC. Nevertheless, it is important to
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note that it remains difficult to be certain that the effect of the drugs on differentiation is due
to a direct effect of the drug on its know target or on some off-target effect. One method to
resolve this issue would be to act on the pathway that the drug targets, without using the mole-
cule (e.g. knockdown a drug’s target). For MB-3, a knockdown of KAT2A was performed in
parallel of the use of MB-3 in mesendodermal differentiation (Moris et al., 2018). Both affected
differentiation and the SGE in the same manner, demonstrating that the results indeed seem
to be directly related to the biological inhibition of KAT2A and not to another independent
pathway. Performing the same experiments for the two other drugs would clearly address this
issue, although this might be more challenging for Artemisinin, for which many targets have
been identified [56].
The question then arises of the mechanisms through which these different drugs modulate
SGE. We first assessed whether these drugs affected the entropy of the same genes. For Indo-
methacin and Artemisinin, we showed that indeed the entropy of some of the same genes were
affected but with a weak correlation. In contrast, MB-3 increased SGE through a different set
of genes. This tends to indicate that the modulation of cell-to-cell variability per se, relatively
independently of the gene function involved, is related to a modification of the differentiation
process (see below).
Even if the correlation is weak, drugs reducing cell-to-cell gene expression variability
seemed to affect the entropy of the same genes. Indeed, Artemisinin and Indomethacin both
increased the cell-to-cell variability of 4 genes: ALAS1, TPP1, MFSD2B and MKNK2. ALAS1
gene encodes for a protein involved in the heme production in red blood cells [61]. TPP1 gene,
previously named CLN2, encodes for a soluble lysosomal enzyme involved in metabolism [62].
MFSD2B is a lipid transporter released by erythrocytes and important in bone homeostasis
[63, 64]. MKNK2 encodes the protein MNK2, which is a downstream kinase activated by
MAPK1 [65]. All these genes are related to erythocytes but no common function emerges,
which prohibits the identification of a core network gene, targeted by drugs to reduce simulta-
neously the level of SGE and the differentiation. Moreover, Artemisinin and Indomethacin
decreased the noise of LDHA and MTFR1 genes, whereas MB-3 increased it. These genes are
known to be involved in the metabolic switch that has been shown to be a key for the avian
erythroid differentiation process [31]. Drugs could control SGE and differentiation though the
modulation of the metabolic pathway needed to progress during the erythropoiesis. For fur-
ther analyses, it could be interesting to further investigate these metabolic genes and the influ-
ence of their SGE change on the differentiation process.
It is important to note that our work focuses on genes that encode for erythroid differentia-
tion and might not represent all genes. Overall it is advisable to use more caution when inter-
preting the importance of the role of gene affected by drugs in this study.
Thus, we can not exclude that there may exist another set of genes preferentially affected by
drug that increase SGE.
We then investigated a potential role for variation in the mean gene expression that could
explain the variation of the level of SGE.
Modifying the level of SGE is accompanied by a variation in the mean gene expression level
for two drugs out of three. The decrease of mean gene expression under MB-3 treatment has
been shown not to be significant in a different system [13]. Also, it has not been reported that
Artemisinin affects mean gene expression in any other cellular system. However, the fact that
Indomethacin treatment decreased gene-wise entropy clearly without affecting the mean
gene-wise expression level reinforces the fact that the modification on the differentiation pro-
cess is not associated to a modification in mean gene expression but only to a non-specific
modulation of SGE.
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Collectively, these results suggest that neither common genes nor common mechanisms
could explain the observed effect of the three drugs simultaneously. This reinforces the fact
that modulation of cell-to-cell variability is strongly accompanied by a change of differentia-
tion, independently of a gene function or a specific mechanism involved.
This could be explained by adopting a dynamical systems view on the differentiation pro-
cess, in the wake of Waddington’s proposal [66]. In such a view, we could consider that in the
highly dimensional gene expression space, an equilibrium cell state could be compared to a
valley in an epigenetic landscape [26]. It has been shown that entropy is a useful tool for ana-
lyzing stochastic processes [67] and distinguishes between equilibrium and transition states
[50]. When we reduce SGE using Indomethacin or Artemisinin, we dig the valley, limiting the
ability of cells to escape from a self-renewal equilibrium. Their probability to reach the new
equilibrium state is reduced. Inversely, when we increase SGE using MB-3, we flatten the valley
and improve the ability of cells to explore a larger dynamical landscape, and increase their
probability to reach the new differentiated equilibrium state. Alternatively, we could think that
drugs modulate differentiation dynamics, flattening or digging valleys, allowing cells to
increase or decrease their probability to escape from the valley. Cells will experience a modula-
tion of the amount of SGE as the consequence of their stability in the high dimensional gene
expression space. Once cells achieve their journey, they stabilize their new gene expression pat-
tern (the differentiated genetic profile) and return to a basal level of SGE [25, 26, 28]. In such a
view, stochastic gene expression favours cells making the decision to differentiate, modifying
the structure of the valley in which cells are moving. In a recent perspective, this same process
of actively shaping the Waddington Landscape has been described in terms of a Plinko board,
whose nail configuration, composition, and patterning can be modified towards forward sto-
chastic design [12]. Similarly to our initial description [31], the variation of cell-to-cell gene
expression in other differentiation systems has been recently described [13, 32–34, 68]. Fur-
thermore, a strong evidence of the relation between transcriptional heterogeneity and cell fate
transitions was demonstrated recently through destabilization of the histone acetylation lead-
ing simultaneously to an increase of SGE and differentiation of mouse embryonic stem cells
[13] and myogenic progenitors [36]. This is fully backed up by our own data that also establish
that the inverse (reducing simultaneously differentiation and SGE) can also be demonstrated.
Conclusion
We show in primary erythroid progenitor cells that a pharmacological modification of SGE is
consistently accompanied by a modulation of the differentiation process. Similar experiments
using the design principles described above can be used to help establish the contribution of
variability to biological processes and to separate cause from consequence [45]. It could there-
fore be important to study the potential use of such drugs in differentiation-related diseases
such as tumoral cell progression [69], as exemplified by chronic myeloid leukemia [12, 70, 71],
paving the way to a “treatment by noise” of at least some cancer-related diseases.
Supporting information
S1 Fig. In sillico interaction analysis between drugs’ targets. Representation of connections
among known three drugs’ targets using the STRING database (http://string.embl.de/). Each
edge between two proteins corresponds to a known association between those proteins. In this
figure, the two cyclooxygenases COX-1 and COX-2 are respectively named PTGS1 and PTGS2
for prostaglandin-endoperoxide synthase (their official name).
(PDF)
Role of stochastic gene expression during differentiation process
PLOS ONE | https://doi.org/10.1371/journal.pone.0225166 November 21, 2019 14 / 19
S2 Fig. Gene expression distributions. For each treatment, we represent the gene expression
distribution for the genes with the most negatively affected entropy (left panel) and for the
genes with the most positively affected entropy (right panel), as defined in Table 1. We display
the distribution for the treated condition in red and the distribution for the control condition
in black.
(PDF)
S3 Fig. The model reproduces the cellular kinetics observed in vitro. Simulation of the
model in the untreated (black) and treated cases (color). Solid lines represent a simulation of
the best model selected by Akaike’s weights. Dots and triangles are the experimental data
(n = 3). On the left and the center are respectively displayed the total number of living cells in
self-renewing (LM1) and differentiated (DM17) media (in log-scale). On the right are dis-
played the fraction of differentiated cells (in percentage) in differentiated (DM17) medium.
(PDF)
S4 Fig. Drugs do not change the erythroid commitment. T2EC were induced to differentiate
for 24 (solid lines) and 48 (dashed lines) hours and subsequently seeded back in self-renewal
conditions. Cells were then counted every day for 3 days. The data shown are the mean ± stan-
dard deviation calculated on the basis of three independent experiments. The growth ratio was
computed as the cell number divided by the total cells at day 0.
(PDF)
S5 Fig. Model selection by Akaike’s weights. Shown are the Akaike weights of the models,
sorted from best to worst. For readability, the worst models were omitted. For each drug, the
coloured bars represent the models which amount to 95% of the overall Akaike’s weight.
(PDF)
S6 Fig. Drug toxicity in T2EC. Measurements of drug toxicity in self-renewal medium (left
panel) and in differentiation medium (right panel) have been performed. In black are repre-
sented the control conditions. Treated conditions are represented in color. Cell toxicity for
Indomethacin, Artemisinin treatment and their control was performed at 48h of differentia-
tion. For MB-3 treatment and its control, the cell toxicity was performed at 24h of differentia-
tion. Each drugs toxicity has been tested with the adequat concentration used in the study.
Wilcoxon tests were performed between each pair of control and treated conditions. All tests
were negative for a significant difference between control and treatment (p-value < 0.05,
n = 3).
(PDF)
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